BACHEM HOLDING AG (BANB)

Currency in CHF
74.80
-2.20(-2.86%)
Closed·
BANB is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
74.8082.30
52 wk Range
48.5283.25
Key Statistics
Bid/Ask
74.00 / 77.50
Prev. Close
77
Open
78.95
Day's Range
74.8-82.3
52 wk Range
48.52-83.25
Volume
225.39K
Average Volume (3m)
144.87K
1-Year Change
8.0144%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BANB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
81.40
Upside
+8.82%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 28 consecutive years

BACHEM HOLDING AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

6 Buy
3 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 81.40
(+8.82% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Deutsche Bank
Buy88.00+17.65%80.00MaintainJul 31, 2026
UBS
Buy88.00+17.65%80.00MaintainJul 31, 2026
Barclays
Hold70.00-6.42%65.00MaintainJun 09, 2026
Deutsche Bank
Buy80.00+6.95%75.00MaintainMar 16, 2026
UBS
Buy80.00+6.95%78.00MaintainMar 13, 2026

BACHEM HOLDING AG Earnings Call Summary for H1/2026

  • Bachem H1 2026 sales rose 4% to CHF 326.4M (7.3% in local currencies); EBITDA margin slipped to 25.4% from 25.9% year-over-year amid expansion costs.
  • New Building K facility produced first commercial GMP material but contributed no H1 sales; expected to drive meaningful revenue in second half of 2026.
  • Company narrowed full-year 2026 sales growth guidance to 35-40% in local currencies from prior 35-45% range; EBITDA margin outlook held at low 30s.
  • Management reports all orders for remainder of 2026 already booked; CapEx guidance reduced to CHF 350-400M reflecting timing adjustments, not strategy change.
  • Free cash flow expected to turn positive in 2029; net debt at CHF 157M with 0.8x leverage as company continues CHF 500M+ Sisslerfeld expansion program.
Last Updated: 2026-07-30, 05:06 a/m
Read Full Transcript

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.98%
Dividend Yield
1.17%
Industry Median 0.96%
Annualized payout
0.90
Paid unevenly
5-Years Growth
+6.72%
Growth Streak

BANB Income Statement

Compare BANB to Peers and Sector

Metrics to compare
BANB
Peers
Sector
Relationship
P/E Ratio
37.6x14.5x−0.3x
PEG Ratio
3.600.090.00
Price/Book
3.9x3.7x2.6x
Price / LTM Sales
7.9x2.7x3.0x
Upside (Analyst Target)
14.3%45.3%56.7%
Fair Value Upside
Unlock14.2%9.4%Unlock

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.39M9.86%543.98M
Other Institutional Investors
5.15M6.87%379.03M
Public Companies & Retail Investors
62.39M83.26%4.59B
Total
74.94M100.00%5.52B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Capital Research and Management Company4.99%3,738,612275,162
UBS Asset Management AG3.04%2,277,835167,649

People Also Watch

602.00
VACN
-0.23%
43.80
PPGN
-0.34%
14.69
SIGNC
-3.04%
75.75
SFZN
+0.07%
55.38
ALCC
-1.32%

FAQ

What Is the BACHEM HOLDING AG (BANB) Stock Price Today?

The BACHEM HOLDING AG stock price today is 74.80 CHF.

What Stock Exchange Does BACHEM HOLDING AG Trade On?

BACHEM HOLDING AG is listed and trades on the Switzerland Stock Exchange.

What Is the Stock Symbol for BACHEM HOLDING AG?

The stock symbol for BACHEM HOLDING AG is "BANB."

Does BACHEM HOLDING AG Pay Dividends? What’s The Current Dividend Yield?

The BACHEM HOLDING AG dividend yield is 1.17%.

What Is the BACHEM HOLDING AG Market Cap?

As of today, BACHEM HOLDING AG market cap is 5.61B CHF.

What Is BACHEM HOLDING AG's Earnings Per Share (TTM)?

The BACHEM HOLDING AG EPS (TTM) is 1.98.

When Is the Next BACHEM HOLDING AG Earnings Date?

BACHEM HOLDING AG will release its next earnings report on Jul 30, 2026.

From a Technical Analysis Perspective, Is BANB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has BACHEM HOLDING AG Stock Split?

BACHEM HOLDING AG has split 3 times.

How Many Employees Does BACHEM HOLDING AG Have?

BACHEM HOLDING AG has 2363 employees.

What is the current trading status of BACHEM HOLDING AG (BANB)?

As of Aug 01, 2026, BACHEM HOLDING AG (BANB) is trading at a price of 74.80 CHF, with a previous close of 77.00 CHF. The stock has fluctuated within a day range of 74.80 CHF to 82.30 CHF, while its 52-week range spans from 48.52 CHF to 83.25 CHF.

What Is BACHEM HOLDING AG (BANB) Price Target According to Analysts?

The average 12-month price target for BACHEM HOLDING AG is 81.40 CHF, with a high estimate of 110 CHF and a low estimate of 52 CHF. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +8.82% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.